SPIA
MURA

Steward Partners Investment Advisory’s Mural Oncology MURA Stock Holding History

Steward Partners Investment Advisory’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,100
Closed -$5.19K – 4339
2025
Q2 		$5.19K Hold
2,100
– – ﹤0.01% 3471
2025
Q1 		$2.65K Sell
2,100
-3,000
-59% -$10.9K ﹤0.01% 3576
2024
Q4 		$16.4K Buy
+5,100
New +$18K ﹤0.01% 2887
2024
Q2 		– Sell
-15
Closed -$73 – 3677
2024
Q1 		$73 Hold
15
– – ﹤0.01% 3511
2023
Q4 		$89 Buy
+15
New +$60 ﹤0.01% 3444

Other funds holding MURA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Steward Partners Investment Advisory's MURA Position: Q3 2025 in Review

Steward Partners Investment Advisory sold out of Mural Oncology (MURA) in Q3 2025, closing a stake of 2,100 shares — an estimated $5.19K sold.

Steward Partners Investment Advisory first reported a position in MURA in Q4 2023 and held it in 5 quarters. The position peaked at $16.4K in Q4 2024. 61 funds tracked by Wall St. Rank hold MURA as of Q3 2025.

  • Steward Partners Investment Advisory reported no remaining Mural Oncology position as of Q3 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 2,100 Mural Oncology shares in Q3 2025, an estimated $5.19K.
  • Steward Partners Investment Advisory first reported a position in Mural Oncology in Q4 2023 and held it in 5 quarters.
  • Steward Partners Investment Advisory's Mural Oncology position peaked at $16.4K in Q4 2024.
  • 61 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2025, filed 12 Nov 2025.